The evaluation of drug safety and toxicology has benefited in recent years from biomarker applications, particularly in the area of biomarker discovery. As the number of drugs and drug targets grows, there is a commensurate need for readily measurable markers that can provide an early indicator of undesirable side effects. Toxicological risk-assessment process for pharmaceutical or other compounds is always incomplete and associated with uncertainties.